Biotechnology

NOTABLE LABS LTD

Earnings Report Released on August 14, 2024: EPS -0.9729, Net Loss -8,985,000 USD, Revenue 3,000 USD

Earnings Report Released on August 14, 2024: EPS -10.0041, Net Loss -9.707M USD, Revenue 0

Earnings Report Released on May 15, 2024: EPS -6.4646, Profit -6,272,000 USD

Earnings Report Released on May 15, 2024 for ST/US/NTBLQ: EPS -0.4175, Revenue $1,000

Company 'ST/US/NTBLQ' released 2022 earnings report on April 11, 2024, with EPS -21.9731 and revenue 8,000 USD

Company 'ST/US/NTBLQ' released earnings report on April 11, 2024, with EPS -3.4104 and revenue 310,000 USD

Earnings Report for ST/US/NTBLQ on November 29, 2023: Revenue 122,000 USD, EPS -9.8169 USD

EKSO Bionics

Profusa

Antelope Enterprise

Cemtrex

FLY-E

Borealis Foods

CID Holdco

Zhongchao

ON24

Aimei Health Tech

Adma Biologics

Kiniksa Pharmaceuticals

Stoke Therapeutics

Rigel Pharma

OpGen

Vertex Pharma

Regeneron Pharma

Alnylam Pharma

Argenx

Beigene

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap